1. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol;Beck;Am J Ophthalmol,2003
2. Predictive identification of the fastest progressing geographic atrophy lesions based on deep learning in the phase 2 FILLY clinical trial of Pegcetacoplan;Bogunovic;Invest Ophthalmol Vis Sci,2021
3. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 -. Identifier NCT02247479, A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA); 2019 Jun 26 [cited 2023 Aug 23]; Available from: 〈https://clinicaltrials.gov/ct2/show/NCT02247479〉.
4. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 -. Identifier NCT02247531, A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (SPECTRI); 2019 Oct 15 [cited 2023 Aug 23]; Available from: 〈https://clinicaltrials.gov/ct2/show/NCT04770545〉.
5. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 -. Identifier NCT03525600, Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration